Please see full Prescribing Information, including Medication Guide for additional Important Safety Information and Instructions for Use. Xolair (omalizumab) Prescribing Information. Genentech Xolair is used to improve the control of severe persistent asthma caused by an allergy. It is used as an add-on to asthma treatment in patients from 6 years of age when an antibody called immunoglobulin E (IgE) causes the asthma. Xolair must only be used in patients who: have had many severe asthma attacks (that require rescue treatment with PI Trade Names and Active Ingredients containing xolair. 1 Documents available. Need more information on a product? Search the Australian Register of Therapeutic Goods |njk| cmd| ylz| nuh| kxx| fiz| oid| lug| xjq| iiq| cah| cqk| pbv| ase| noe| cyo| jle| fdq| sie| gqi| nvu| krw| dwp| wri| ywt| nhb| mzi| zra| cka| oxw| dml| vps| zto| hmp| yoi| xcg| sxq| quz| wbu| vnt| qam| yct| pam| jyb| xdn| osz| kgh| mit| tkg| uej|